PRIA Logo™
115-hr-6294115th Congress

REVAMP Act

Sponsored By: Representative JOHN SHIMKUS

Unknown

Summary

Re-Valuing Anti-Microbial Products Act of 2018 or the REVAMP Act This bill amends the Federal Food, Drug, and Cosmetic Act to provide for an award of 12 additional months of market exclusivity to a drug manufacturer for a drug designated as a "priority antimicrobial product." (A priority antimicrobial product is intended to treat or prevent a disease attributable to a multi-drug resistant bacterial or fungal pathogen for which there is a critical unmet medical need.)

Personalized for You

How does this bill affect your finances?

Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Free to download

Bill Overview

No Economic Impacts Identified for this Bill

Sponsors & CoSponsors

Sponsor

JOHN SHIMKUS

IL • R

Cosponsors

  • Rep. Cárdenas, Tony [D-CA-29]

    CA • D

    Sponsored 6/28/2018

  • Rep. Eshoo, Anna G. [D-CA-16]

    CA • D

    Sponsored 7/24/2018

Roll Call Votes

No roll call votes available for this bill.

View on Congress.gov
Back to Legislation